20 likes | 141 Views
Fanconi Anemia Overall Survival Unrelated Transplantation using Non-myeloablative Preparative Regimens for Pediatric Patients, by Cell Source (2000
E N D
1. Additional presentation notes are included to supplement the slide content. To print notes pages, select Notes Pages in your printer window.
When used in presentations, the slides should retain their appearance and design. To copy slides into another presentation:
Select and copy the slide(s) you want to include.
Paste the slide(s) into the new presentation. A Copy button will appear next to the copied slides.
Click the Copy button and click the drop-down arrow that appears. Two options will be available.
Select Keep Source Formatting.
Additional presentation notes are included to supplement the slide content. To print notes pages, select Notes Pages in your printer window.
When used in presentations, the slides should retain their appearance and design. To copy slides into another presentation:
Select and copy the slide(s) you want to include.
Paste the slide(s) into the new presentation. A Copy button will appear next to the copied slides.
Click the Copy button and click the drop-down arrow that appears. Two options will be available.
Select Keep Source Formatting.
2. Fanconi Anemia Overall SurvivalUnrelated Transplantation using Non-myeloablative Preparative Regimens for Pediatric Patients, by Cell Source (2000–2009) The NATIONAL MARROW DONOR PROGRAM® operates the Be The Match Registry®. This survival graph illustrates outcomes of unrelated donor marrow and peripheral blood stem cell (PBSC) transplants using non-myeloablative preparative regimens for Fanconi anemia coordinated by the National Marrow Donor Program (NMDP) for pediatric patients (<18 years) between 2000 and 2009.
There is no statistically significant difference in overall survival due to stem cell source (marrow or PBSC) in non-myeloablative unrelated donor transplantation in pediatric patients with Fanconi anemia (log-rank p-value = 0.297).This survival graph illustrates outcomes of unrelated donor marrow and peripheral blood stem cell (PBSC) transplants using non-myeloablative preparative regimens for Fanconi anemia coordinated by the National Marrow Donor Program (NMDP) for pediatric patients (<18 years) between 2000 and 2009.
There is no statistically significant difference in overall survival due to stem cell source (marrow or PBSC) in non-myeloablative unrelated donor transplantation in pediatric patients with Fanconi anemia (log-rank p-value = 0.297).